Media ReleasesOventus Medical

View All Oventus Medical News


Oventus announce First US Agreements Signed with Sleep Medicine Groups

Oventus enters into first agreements with American sleep medicine groups to deliver the O2Vent® Sleep Treatment Platform to patients under the ‘lab in lab’ model

Key points:

  • Oventus signs first material agreements with sleep medicine groups in the United States for its O2Vent® Sleep Treatment Platform which treats obstructive sleep apnoea (OSA)
  • The exclusive agreements to supply dental sleep medicine solutions are with 8 sleep facilities in Texas, Arizona and New Mexico
  • Contracts further validate demand for Oventus sleep treatment platform and ‘lab in lab’ delivery model
  • Oventus expects to secure further agreements across North America over the next 12-24 months
  • Negotiations ongoing with multiple groups across Canada, the US and Australia with a view to significant scaling through the end of calendar 2019 and 2020
For further information please download the attached PDF: Download this document